Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-11-08Clinical Trial Update: Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients [Phase 2]
Phase IIa randomized, multicenter, open-label study to identify the better intraperitoneal dose of Removab (catumaxomab) in platinum-refract…
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial of an oral VEGFR-2 tyrosine kinase inhibitor for small-volume ovarian, peritoneal, and fallopian tube cancers…
-
CLINICAL_TRIALS research · 2006-10-06Clinical Trial Update: Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma [Phase 2]
Phase 2 clinical trial update on intraperitoneal hyperthermic chemotherapy for epithelial ovarian cancer (FIGO stage IIIC).
-
CLINICAL_TRIALS trial_result · 2006-10-02Clinical Trial Update: Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ACA 125 in patients with ovarian cancer, focusing on safety and immune response.
-
CLINICAL_TRIALS trial_result · 2006-09-15Clinical Trial Update: Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Gemzar (gemcitabine) and Alimta (pemetrexed) in patients with recurrent platinum-sensit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: Weekly Topotecan Therapy in Patients With Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating weekly topotecan for ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Massage Therapy for Cancer-Related Fatigue [Phase 2]
Phase 2 clinical trial update evaluating massage therapy to reduce cancer-related fatigue.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Acupuncture to Improve Quality of Life in Patients With Advanced Cancer [Phase 2]
Phase 2 clinical trial update assessing whether acupuncture improves quality of life in patients with advanced ovarian cancer. The study sta…
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer [Phase 3]
Phase 3 trial evaluating the combination of paclitaxel, carboplatin, and topotecan in patients with ovarian cancer has completed.